Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for MICAFUNGIN
- Antimicrobial Revision in Persistent Febrile Neutropenia
- Evaluate Bioequivalence of Micafungin (50mg/Vial)
- A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole
- Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors
- To Evaluate the Efficacy and Safety of Micafungin in Preventing Invasive Mycosis After Liver Transplantation
- Comparison of Two Diagnostic Tests in Patients With Suspected Invasive Candidiasis in Internal Medicine Wards and Who Are Currently Timely Treated With Micafungin
- Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida Meningitis
- Micafungin Pharmacokinetics in Obese Patients
- Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis
- Prevention of Clostridium Difficile-associated Diarrhea by Daily Intake of Kefir
- A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections
- Pharmacokinetics of Micafungin During Continuous Venovenous Hemofiltration
- Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp
- Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis
- Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute Leukemia
- A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area
- Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis
- Pharmacokinetics of Micafungin Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease
- Fluconazole Versus Micafungin in Neonates With Candidiasis
- Use of Micafungin (Mycamine®) as Antifungal Prophylaxis in Haematology and Onco-haematology
- A Pharmacokinetic Study of Pediatric Micafungin Prophylaxis
- A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia
- Micafungin Versus Fluconazole for Prevention of Invasive Fungal Disease in Living Donor Liver Transplant Recipients
- Evaluation of Budesonide and How It Interacts With Antifungal Drugs in People With Gastrointestinal Graft-Versus-Host Disease
- Antifungal Prophylaxis With Micafungin After Cord Blood Allogeneic Stem Cell Transplantation (MycaCOORD)
- PEACE: Pediatric Antifungal Comparative Effectiveness
- Pharmacokinetics of Micafungin in Patients Intensive Care Unit
- Empirical Antifungal Treatment in ICUS
- Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents
- Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation
- Micafungin Prevention Study for Invasive Fungal Disease in Pediatric & Adolescent Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
- Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases
- Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis
- Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome
- Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation
- A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects
- Drug Concentration Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers
- Liver Transplant European Study Into the Prevention of Fungal Infection
- Alternate Day Micafungin: A PK Study in Pediatric Patients
- Comparison of Candida Eradication and Serum Cidal Activity of Echinocandins
- An Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in Neonates
- Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis
- Micafungin Lock Therapy
- A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)
- Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis
- Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis
- Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug
- Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug
- A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell Transplant
- A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive Aspergillosis
- Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis
- Micafungin Salvage Mono-therapy in Invasive Aspergillosis
- Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients
- Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia
- Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia
- Study of Micafungin in Patients With Invasive Candidiasis or Candidemia
- Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU
- Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for Aspergillosis
Clinical trials list
click for details